ADRB2 and asthma: Previoius hypothesis attributed the loss of bronchoprotection after chronic use of β2AR agonists to the reduction in β2AR synthesis and density over the cell surface by internalization, but it cannot completely explain the bronchoprotective effects induced by βAR inverse agonists in spite of an increase of lung βAR density after nadolol in rat asthma model9.